29. Dietary reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Manganese, Molibdenium, Nikel, Silicon, Vanadium and Zinc. Food and Nutrition Board (FNB), Institute of Medicine (IOM). The National Academies Press. Washington, DC. 2002. 773 p.
30. Dietary Reference Values for Food Energy and Nutrient for the United Kingdom. Report of the panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. HMSO, London, 1991.
31. Dietary Reference Intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin В12, pantothenic acid, biotin and choline. Washington, D.C., Ed. Nat. Acad. Press. 2000. 592 p.
32. Dietary Reference Intakes for vitamin C, vitamin E, selenium and carotenoids. Washington, D.C., Ed. Nat. Acad. Press. 2000. 529 p.
33. Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Standing Committee on the scientific evaluation of dietary reference intakes, food and nutrition board, Institute of Medicine // Washington, DC: National Academy Press. 1997.
34. Fritz I. Carnitine and its role in fatty acids metabolism // Adv. Lipid Res. 1963; 1:85-334.
35. Fuhrman В., Ben-Yaish L., Attias J. et al. Tomato lycopene and b-carotene inhibit low density lipoprotein oxidation and this effect depends on the lipoprotein vitamin E content // Nutr. Metab. Cardiovasc. Dis. 1997. Vol. 7. № 6. P.433-443.
36. Health Council of the Netherlands. Dietary reference intakes: energy, proteins, fats and digestible carbohydrates. Publication 2001/19 // The Hague: Health Council of the Netherlands. 2001.
37. Geleijnse J.M., Launer L., Hofman A. et al. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study // Arch. Intern. Med. 1999. Vol. 159. P. 2170-2174.
38. Golub I. Effect of esterin process alfalfa in diabetic patients with hyperlipoproteinaemia upon serum lipid parameters // World Health Organization Clinical Research. 1992.
39. Graham H.N. Green tea composition, consumption, and poly-phenol chemistry // Prev. Med. 1992. Vol. 21. P. 334-350.
40. Han L.K., Takuku., Li J., Kimura Y., Okuda H. Anti-obesity action of oolong tea // Int J Obes Relat Metab Disord. 1999; 23(1): 98- 105.
41. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency //Biochem. Pharmacol. 1983. Vol. 32. P. 1141- 1148.
42. Hertog M. Flavonos in wine and tea and prevention of coronary heart disease. Paris: Polyphenols 96. Ed. INRA, 1998. P. 117-131.
43. Hobbs С The Echinacea Handbook. Eclectic Medical Publications, Portland, OR. 1989.
44. Hollman P.C, Katan M.B. Absorption, metabolism and health effects of dietary flavonoids in man // Biomed. Pharmacother. 1997. Vol. 51. № 5. P. 305-310.
45. Jain A.K. et al. Can garlic reduce levels of serum lipids? A controlled clinical study // Am. J. Med. 1993. Vol. 94. P. 632-635.
46. Kalka S/P/ Appetite and body weight regulation: is it all in brain // Neuron. 1997; 19:227-30.
47. Kawada T. Et al. Effects of capsaicin in lipid metabolism in rats fed a high fat diet // J. Nutr. 1986; 116: 1272-1278.
48. Kartnig T. Clinical applications of Centella asiatica (L.) // Urb. Herbs Spices Med. Plants. 1988. Vol. 3. P. 146-173.
49. Kendler B.S. Garlic (Allium sativum) and onion (Allium сера): A review of their relationship to cardiovascular disease. Prev. Med. 1987. Vol. 16. P. 670-685.
50. Kimua Y., Atanabe K., Okuda H. Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats // J. Ethnopharmacol. 1996; 54:47-54.
51. Knekt P., Kumpulainen J., Jarvinen R. et al. Flavonoid intake and risk of chronic diseases // Ann. Nutr. Metab. 2001. Vol. 45. Suppl 1. P. 256.
52. Kuhnau J. The flavonoids, a class of semi-essential food components: Their role in humane nutrition // World Rev Nutr Diet. 1976. Vol. 24. P. 117-191.
53. Law M. Plant sterol and stanol margarines and health // British Med. J. 2000. Vol. 320. P. 861-864.
54. Lee Y.В., Kim Y.S., Ashmore С.R. Antioxidant property in ginger rhizome and its application to meat products // J. Food Sci. 1986. Vol. 51. P. 20-23.
55. Maezaki Y., Tsuji K., Nakagawa Y. Et al/ Hypocholesterolemic effect of chitosan in adult males // Biosci. Biotechnol. Biochem. 1993; 57:1439-1444.
56. Milner J.A. Functional foods and health: a US perspective // Brit. J. Nutr. 2002. Vol. 88. Suppl. 2. P. S151- S158.
57. National Hearth Foundation of Australia. A review of the relationship between dietary fat and cardiovascular disease // Australian J. Nutr. Diet. 1999. Vol. 56. Suppl. 4. P. S5-S22.
58. Nijveldt R., Nood E., Hoorn D. et al. Flavonoids: a review of probable mechanisms of action and potential applications // Am. J. Clin. Nutr. 2001. Vol. 74. № 4. P. 418-425.
59. Peterson J., Dwyer J. Flavonoids: dietary occurrence and biochemical activity // Nutr. Res. 1998. Vol. 18. № 12. P. 1995-2018.
60. Pienta K.J., Esper P.S. Risk factors for prostate cancer // Ann. Intern. Med. 1993; 118:793-803.
61. Preuss H.G., Anderson R.A. Chromium update: examining recent literature 1997-1998 // Curr. Opin. Clin. Nutr. Metab. Care. 1889; 1(6): 509-12.
62. Recommended Daily Amounts of Vitamin and Minerals in Europe. // Nutrition Abstracts and Revievs, Series A. 1990. V. 60. № 10.
63. Riales R., Albrik M.J. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men // Am. J. Clin. Nutr. 1981; 34:2670-2678.
64. Roberfroid M. B. Global view on functional foods: European perspectives // Brit. J. Nutr. 2002. Vol. 88. Suppl. 2. P. S133-S138.
65. Salvadori M.C., Rieser E.V., Ribeiro Neto L.V., Nascimento E.S. Determination of xanthines by high-performance liquid chromatography and thn-layer chromatography in horse urine after ingestion of Guarana powder // Analyst. 1994; 119(12):2701-03.
66. Schwitters В and Masquelier J. OPC in practice: biflavanols and their application // Alfa Omega, Rome, 1993.
67. Sha А.К., Vawas D., Kurowski T.G. et al. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle // Am. J. Physiol. 1997; 272:641-48.
68. Taussig S. et al. Bromelain, a proteolytic enzyme and its clinical application. A review // Hiroshima J. Med. Sci.-1975. Vol. 24. P. 185- 193.
69. Trace elements in human nutrition and health. Geneva: WHO. 1996. 343 р.
70. Wang Q., Bing., Al-Barazanji K. et al. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat // Diabetes. 1997; 46:335-341.
71. Wang Q., Bing., Al-Barazanji K. et al. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat // Diabetes. 1997; 46:335-341.
72. Watanabe T. et al. Capsaicin, a pungent principle of hot red pepper, evokes catecholamine secretion from the adrenal medulla of anesthetized rats // Biochem. Biophys. Res. Comm. 1987; 142:259-64.
73. Yaamoto M., Shimura S., Itoh Y. et al. Anti-obesity effects of lipase inhibitor CT-11, an extract from edible herbs, Nomame Herba, on rats fad a high-fat diet // Int. J. Obes. Relat Metab. Disord. 2000 Jun; 24(6):758-764.
Содержание
Введение
1. Область применения
2. Общие положения
3. Термины и определения
4. Нормативные ссылки
Приложение. Рекомендуемые величины суточного потребления пищевых и биологически активных веществ для взрослых в составе продуктов диетического (лечебного и профилактического) питания и БАД к пище (энергетическая ценность 10000 кДж или 2300 ккал
Список литературы